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The reliable assessment of proarrhythmic risk of compounds under development remains an elusive goal. Current safety guidelines focus
on the effects of blocking the KCNH2/HERG ion channel-in tissues and animals with intact repolarization. Novel models with better pre-
dictive value are needed that more closely reﬂect the conditions in patients with cardiac remodelling and reduced repolarization reserve.
EXPERIMENTAL APPROACH
Wehavedeveloped amodel for the longQT syndrome type-5 in rabbits (LQT5 )with cardiac-speciﬁc overexpression of amutant (G52R)
KCNE1 β-subunit of the channel that carries the slowdelayed-rectiﬁer K+-current (IKs). ECG parameters, including short-term variability of
the QT interval (STVQT), a biomarker for proarrhythmic risk, and arrhythmia development were recorded. In vivo, arrhythmia suscepti-
bility was evaluated by i.v. administration of the IKr blocker dofetilide. K
+ currents were measured with the patch-clamp technique.
KEY RESULTS
Patch-clamp studies in ventricular myocytes isolated from LQT5 rabbits revealed accelerated IKs and IKr deactivation kinetics. At
baseline, LQT5 animals exhibited slightly but signiﬁcantly prolonged heart-rate corrected QT index (QTi) and increased STVQT.
Dofetilide provoked Torsade-de-Pointes arrhythmia in a greater proportion of LQT5 rabbits, paralleled by a further increase in STVQT.
CONCLUSION AND IMPLICATIONS
We have created a novel transgenic LQT5 rabbit model with increased susceptibility to drug-induced arrhythmias that may
represent a useful model for testing proarrhythmic potential and for investigations of themechanisms underlying arrhythmias and
sudden cardiac death due to repolarization disturbances.Abbreviations
HERG, human ether-a-go-go gene; ICa,L, L-type Ca
2+ current; IK1, inward rectiﬁer potassium current; IKr, rapid delayed
rectiﬁer potassium current; IKs, slow delayed rectiﬁer potassium current; Ito, transient outward potassium current; KCNE1,
potassium voltage-gated channel subfamily E member 1; LQT5, long QT syndrome type 5; minK, minimum sequence
required for a potassium current; QTi, heart rate-corrected QT index; STVQT, short-term variability of the QT interval;
STVRR, short-term variability of the RR interval; TdP, Torsade-de-Pointes; TG, transgenic; WT, wild type
Tables of Links
TARGETS
Voltage-gated ion channels
KCNQ1/KvLQT1, Kv7.1 channels
LIGANDS
Dofetilide
Nisoldipine
HMR 1556
These Tables list key protein targets and ligands in this article which are hyperlinked to corresponding entries in http://www.guidetopharmacology.
org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) and are permanently archived in the
Concise Guide to PHARMACOLOGY 2015/16 (Alexander et al., 2015).
LQT5 transgenic rabbits BJPIntroduction
In cardiac myocytes, the ion channel that carries the slow
delayed-rectiﬁer K+-current (IKs) is composed of a pore-forming
α(KCNQ1/KvLQT1) and a modulatory β-subunit (KCNE1/minK)
(Barhanin et al., 1996; Sanguinetti et al., 1996. AlthoughKCNQ1
alone forms a voltage-gated K+-channel, KCNE1/minK is
required to reproduce the kinetic properties of native IKs
(Sanguinetti et al., 1996). IKs is an important determinant of
myocardial repolarization, particularly with increased adrener-
gic stimulation (Bennett and Begenisich, 1987; Han et al.,
2001), and is a key contributor to repolarization reserve in
mammalian and human myocardium (Varro et al., 2000; Jost
et al., 2005; Jost et al., 2007). Repolarization reserve refers to
the redundant repolarizing capacity of the myocardium, that
is, with loss of function of a single K+-current, other repolarizing
currents increase to compensate (Roden, 1998, 2006; Varro and
Baczko, 2011). Loss of IKs function reduces this reserve and
makes the heart more vulnerable to arrhythmias (Roden, 2006;
Varro and Baczko, 2011).
KCNE1, also known as minK, was the ﬁrst Kv-channel
accessory subunit cloned from human hearts (Murai et al.,
1989). MinK is a small (129 amino acid) protein with a single
transmembrane spanning domain (Nerbonne and Kass,
2005). Mutations in either KCNQ1 or KCNE1 can alter the
biophysical properties of IKs and KCNE1 mutations are
known to underlie congenital long QT syndrome (LQTS) type
5 (LQT5) (Panaghie et al., 2006).
LQTS, characterized by a prolonged QT-interval, can
cause sudden death by causing a characteristic ventricular
tachycardia known as Torsade-de-Pointes (TdP) (Lehnart
et al., 2007). LQTS can be acquired, following drug treatment,
or be part of an inherited syndrome (Harmer et al., 2010).
Mutations in genes encoding the pore-forming subunits of
the rapid delayed-rectiﬁer K+-current (IKr) and IKs account
for >90% of genotyped LQTS (Moss and Kass, 2005;
Nerbonne and Kass, 2005). Mutations in the KCNE1 gene
are rare and account for ~3% of all LQT mutations (Splawski
et al., 2000).
A complete understanding of the mechanisms by which
individual mutations may lead to arrhythmias and sudden
death requires the study of experimental animal models.
Transgenic mouse models of LQT syndromes have several
limitations (Salama and London, 2007): including heart rates
10 times faster than humans and different repolarizingcurrents (Nerbonne and Kass, 2005). KCNE1 knockout (Drici
et al., 1998; Kupershmidt et al., 1998), knock-in (Rizzi et al.,
2008; Nishio et al., 2009) and loss-of-function mutations
(Demolombe et al., 2001) in transgenic mouse models only
partly mimic the human LQT phenotype (Salama and
London, 2007). The laboratory rabbit (Oryctolagus cuniculus)
has several advantages. The heart rate is slower than in mice.
The larger size of rabbit hearts enables tools developed for the
evaluation of human cardiac function. Moreover, rabbits
have similar repolarizing ion channels to humans
(Nerbonne, 2000). To date, only two transgenic LQT rabbit
models, overexpressing dominant-negative pore mutants of
KvLQT1 (LQT1) or HERG channels (LQT2), have been
described (Brunner et al., 2008). A novel missense mutation,
which leads to a substitution of arginine (R) for glycine (G)
at position 52 of the minK protein, was described in a
Chinese family (Ma et al., 2003). Among seven mutation
carriers, ﬁve were clinically affected; however, two family
members had normal ECG (Ma et al., 2003). In Xenopus
oocytes, co-expression of the mutant G52R-KCNE1 with
KCNQ1 had a dominant-negative effect, reducing IKs by 50%
and prolonging the cardiac action potential (Ma et al.,
2003). The G52R mutation did not alter channel-subunit
assembly or trafﬁcking to the cell membrane but rendered
KCNE1 unable to modulate the gating properties of KCNQ1
in CHO-K1 cells (Harmer et al., 2010).
The present study was designed to create and characterize
an LQT5 rabbit model with reduced repolarization reserve in
order to model impairments of repolarization that are silent
until challenged by an exogenous K+-channel blocking drug
and then potentiate proarrhythmic risk.Methods
Human heart samples
The experimental protocol was approved by the Scientiﬁc and
Research Ethical Committee of the Medical Scientiﬁc Board at
the Hungarian Ministry of Health (ETT-TUKEB: 4991–0/2010-
1018EKU), and followed the principles outlined in the Declara-
tion of Helsinki. Samples from the lateral left ventricular wall
of a non-diseased human heart, technically unusable for trans-
plantation, were obtained from a general organ donor and
were frozen immediately in liquid nitrogen until processing.British Journal of Pharmacology (2016) 173 2046–2061 2047
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All animal care and experimental protocols complied with the
Guide for the Care and Use of Laboratory Animals (USA NIH publi-
cation NO 85–23, revised 1996) and conformed to the Directive
2010/63/EUof the European Parliament; theywere approved by
the Animal Care and Ethics Committee of the Agricultural
Biotechnology Center and the Ethical Committee for the
Protection of Animals in Research of theUniversity of Szeged (ap-
proval number: I-74-5-2012) and by the Department of Animal
Health and Food Control of theMinistry of Agriculture and Rural
Development (authority approval numbers 22.1/433/003/2010
and XIII/1211/2012). Animal studies are reported in compliance
with the ARRIVE guidelines (Kilkenny et al., 2010) and the
editorial on reporting animal studies (McGrath and Lilley, 2015).
New Zealand White rabbits were obtained from Tetrabbit
Kft. (Hungary). The experimental animals were young adults
(approximately 3.5 kg) of either sex, unless otherwise indi-
cated. The animals were kept in stainless steel rabbit cages
containing an elevated resting place and fulﬁlling the re-
quirements of authorities in terms of size and environmental
enrichment. Rabbits were individually housed and were kept
at standard temperature, humidity and lighting. Food and
water were provided ad libitum. The water was provided in
separate drinking bowls to each animal individually and the
water was regularly checked for quality and any pathogens.
Collection of zygotes and laparoscopic transfer of injected
embryos to recipient rabbits was performed as described ear-
lier (Besenfelder and Brem, 1993). Pseudopregnant animals
were moved to a nesting cage 3–4 days before expected deliv-
ery date. For the in vivo ECG studies, rabbits were anaesthe-
tized with ketamine-S/xylazine i.m. (12.5 and 3.5 mg·kg1)
or thiopental (50 mg·kg1) in the marginal ear-vein. At the
end of the arrhythmia provocation experiments, the
anaesthetized animals were killed by i.v. administration of
pentobarbital sodium (RELEASE) in a dose of 300 mg·mL1.Transgene construct
The 4533 bp long rabbit β-myosin heavy chain gene promoter
(r-MYH7) including three untranslated exons were ampliﬁed
with the primers 5′-ACA AAG CCC AGC TCC CTA AT-3′(nt:
2509–2529) and 5′-GGC TGT ACC TGT AGT GAG CG-3′(nt:
7022–7042, Genbank Ac. No.: AF192306.1). PCR was
performed with TaKaRa LA Taq polymerase. Conditions were
95°C for 1 min, 58°C for 45 s and 72°C for 5 min for 35 cycles,
using New Zealand White genomic DNA as template. The
PCR product was cloned into the TOPO site of the pCRW-
Blunt II-TOPO vector with the Zero BluntW TOPOW PCR
Cloning Kit (Invitrogen™, Thermo Fischer Scientiﬁc, Waltham,
MA, USA). The 410 bp human KCNE1 cDNA was isolated from
a human cardiac myocyte cDNA library (Cat no: SC6204; 3H
Biomedical AB, Uppsala, Sweden). The ampliﬁed KCNE1 cDNA
was cloned into the PCR product at the insertion site of the
pSC-A-amp/kan vector with the Strata Clone PCR Cloning
Kit (Stratagene, an Agilent Technologies company, San Diego,
CA, USA). At position 154, a guanine was changed to adenine
with the Quick ChangeW (Agilent Technologies, San Diego,
CA, USA) XL Site Directed Mutagenesis Kit, substituting an
arginine for glycine at amino acid 52 (G52R-KCNE1). The
mutated KCNE1 cDNA was isolated with Eco RV and Sma I
enzymes and blunt-end cloned behind the r-β-MHC promoter2048 British Journal of Pharmacology (2016) 173 2046–2061at the EcoRV site of the pCRW-Blunt II-TOPO vector. The
r-β-MHC promoter-G52R-KCNE1 fragment was isolated with
BamHI and NotI enzymes and cloned into the pcDNA3.1
mammalian expression vector (Invitrogen) containing the
bovine GH poly-A signal. The ~5900 bp long microinjected
fragment, which included the mutated human KCNE cDNA
under the 4533 bp long rabbit β-MHC promoter with three
untranslated exons and the bovine GH polyA tail
(MYH7-G52R-KCNE1-BGHpolyA) was isolated with NheI-SexAI
digestion and puriﬁed with QIAquick gel extraction kit
(Qiagen, Quiagen, Hilden, Germany, Cat no. 28704). The DNA
concentration was set at 4 ng·μL1.
Identification of transgenic animals and transgene
copy number determination
Offspring derived from recipient doeswere screened for transgene
integration by transgene-speciﬁc PCR of genomic DNA puriﬁed
from ear biopsies or blood. The forward primer complementary
to r-MYH7 (5′-GCCTCAGCCAGAACCAGTTA-3′; 5′-GGC TGT
ACC TGT AGT GAG CG-3′) and the reverse oligonucleotides
complementary to h-KCNE1 (5′-GCTTCTTGGAGCGGATGTAG-
3′; 5′-TTA GCC AGT GGT GGG GTT CA-3′) gave rise to a 450
bp diagnostic fragment. PCR conditions were 95°C for 30 s,
54°C for 30 s and 72°C for 45 s for 30 cycles.
Determination of the transgene integration site
with nested PCR
Genomic DNA was digested with Sac I (Fermentas,
Thermo Fischer Scientiﬁc, Waltham, MA, USA, Cat. No.:
ER1131), and the fragments were puriﬁed and incubated with
T4 ligase overnight to produce circular DNA fragments, which
served as templates for nested PCR with primers designed to
hybridize back to back in the 3′ sequence so that the entire cir-
cularized target fragment was ampliﬁed. Primers were: nested1-
F: CAACAGATGGCTGGCAACTA; nested1-R: AGACAATAGCA
GGCATGCTG; nested2-F: AGGAAAGGACAGTGGGAGTG; nes
ted2-R: GACAGCAAGGGGGAGGAT.
Creation of transgenic LQT5 rabbits
The KCNE1 coding region of the transgene was ampliﬁed and
analyzed by automated sequencing (Figure 1). The MYH7-
G52R-KCNE1-bGHpolyA insert was isolated and used to
microinject rabbit embryos. Out of 497 injected embryos,
466 were transferred into 21 pseudopregnant recipients
through laparoscopy. Thirty-eight offspring (8%) were born
alive, out of which four (10%) were transgenic by genomic
PCR (Figure 2A). Three founders lived till sexual maturity.
The female founder did not transmit the transgene to its
offspring, suggesting that it was transgenic in somatic tissues
but not the germ line. The remaining two transgenic founder
males (# G52R-JTJKK and #G52R-JKK) transmitted the
transgene to their offspring from wild-type does at 52% (in
the G52R-JTJKK line) and 15% (in the G52R-JKK line) ratio,
respectively, which in case of the G52R-JTJKK founder
underlines a Mendelian type inheritance. For the #G52R-
JKK founder, the transgene transmission data indicate a high
degree of germ-line mosaicism. Therefore, except where it
is otherwise indicated, for electrophysiological examina-
tions, the F1 hemizygote offsprings of #G52R-JTJKK line
were used and are called transgenic animals in Table 2 and
Figure 1
The G52Rmutation and the transgene construct. Schematic drawing of the mutation in KCNE1 polypeptide (upper panel) and the transgene construct
(middle panel). Mutation G to A at position 154 of human KCNE1 cDNA and wild-type sequence. Sense-strand sequences are shown (lower panel).
LQT5 transgenic rabbits BJPthe Figures. The presence of G52R mutation was checked by
sequencing the PCR product isolated from genomic DNA of
the founder male #G52R-JTJKK. In the #G52R-JTJKK animal,
the transgene was integrated at Σ 10 copies in two different
loci on Chr11, namely at positions chr11:18,313,856 and
chr11:41,935,523.
Organ-specific expression of the transgene
One adult female and amale of #G52R-JTJKK line and theG52R-
JKK founder and its F1 offspring were killed and samples
collected to evaluate the tissue speciﬁcity of transgene expres-
sion. Total RNA was extracted using RNeasy Plus Mini Kit
(Qiagen, Cat. No: 74134). A tissue sample isolated from a
healthy human heart ventricle served as positive control. A total
of 100 ng RNA per sample was used for RT-PCR with High
Capacity cDNA Reverse Transcription Kit (Applied Biosystem,
Thermo Fischer Scientiﬁc, Waltham, MA, USA, Cat. No.:4368814). The program for ﬁrst strand synthesis was 25°C for
10 min, 37°C for 120 min and 85°C for 5 min. The human
G52R-KCNE1 speciﬁc 407 bp amplicon was produced with the
primers (5′-ATG ATC CTG TGT AAC ACC ACA GAG-3′)
(5′-TTA GCC AGT GGT GGG GTT CA-3′) and a 385 bp
endogenous control amplicon from the rabbit α-actin mRNA
with the primer pair: (5′-TGTGACATCGACATCAGGAAGG-3′;
nt 917–938 and 5′-TAGGTAATGAGTCAGAGCTTTGG-3′; nt
1277–1299; MYH6; Genbank: AF192305). Ampliﬁed products
were resolved on 1% agarose gel.
The human G52R-KCNE1 speciﬁc 407 bp amplicon was
detected only in the mRNA from the ventricular part of
hemizygote rabbit’s heart from the two independent lines
(#G52R-JTJK and #G52R-JKK) but was not detected either in
the atrium or other examined organs of the transgenic
rabbits. It was not detected in non-transgenic, littermate
rabbits (Figure 2B and C).British Journal of Pharmacology (2016) 173 2046–2061 2049
Figure 2
Identiﬁcation of G52R founders and tissue speciﬁc transgene expres-
sion. (A) Transgene speciﬁc PCR of genomic DNA of three founders.
Line 1: G52R-JTJKK; line 2: female founder without transgenic
offspring; line 3: G52R-14-JKK; line 4: negative control; and line 5:
positive control (injected construct). (B) Expression proﬁle of
hKCNE1 speciﬁc mRNAs detected by RT-PCR in ventricular myocar-
dium and diverse tissues from transgenic (tr) rabbit #G52R-JTJKK.
β-actin speciﬁc PCR reaction was carried out to control the quality
of RNA and the RT step in all sets of samples (data not shown).
Molecular weight marker: Fermentas Gene Ruler DNA Ladder Mix
(Cat.No.: SM0331); Line 1: transgenic rabbit (tr) smooth muscle;
2: tr striated muscle; 3 tr atrial myocardium; 4: tr ventricular myocar-
dium; 5: tr brain; 6: human ventricle. (C) Expression proﬁle of
hKCNE1 speciﬁc mRNAs detected by RT-PCR in ventricular myocar-
dium and diverse tissues of transgenic rabbit #G52R-JKK. β-actin spe-
ciﬁc PCR reaction was carried out to control the quality of RNA and
the RT step in all sets of samples (data not shown). Molecular weight
marker: Fermentas Gene Ruler DNA Ladder Mix (Cat.No.: SM0331).
Line 1: tr smooth muscle; line 2: tr striated muscle; line 3: tr brain;
line 4: tr right ventricle; line 5: tr left ventricle; line 6: tr atrium.
Table 1
List of primers used in quantitative mRNA determination
Gene Origin Primers
KCNE1 rabbit 5′-CTACATCCGCTCCCAGAAACT-
3′5′-GCTGGTTTTCAAGGACGTAGC
RPS5 rabbit 5′-TAC ATT GCG GTG AAG GAG AA
TCA TCA TGG AGT TGG TGA GG-3
KCNQ1 rabbit 5′-AGGAGCTGATCACCACCCTGTA
ATCTGCGTAGCTGCCGAACTC-3′
MYH7 rabbit 5′-GCCTCAGCCAGAACCAGTTA-3′
5′-GGC TGT ACC TGT AGT GAG CG
28S rabbit 5′-GTTGTTGCCATGGTAATCC
TGCTCAGTACG-3′; 5′-TCTGA
CTTAGAGGCGTTCAGTCATAATCC
BJP P Major et al.
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Heart samples from four F1 hemizygotes (#G52R-JTJKK line) and
four littermate controls were dissected manually to 2 mm tissue
sections, and the samples immediately homogenized for 1 min
with Bullet Blender Storm 24 homogenizer. Total RNA was
isolated from the tissue using an RNAzol RT kit (Molecular
Research Center Inc., Cincinnati, OH, USA). Total RNA was
quantiﬁed with a Nanodrop ND1000 spectrophotometer
(Thermo Fischer Scientiﬁc, Waltham, MA, USA). First-strand
cDNA was synthesized from 100 ng RNA using Tetro cDNA
Synthesis Kit (Bioline, London, UK) reverse transcriptase in a
20 μL reaction, using oligo(dT)18 priming. Aliquots of 1 μL of
the resulting cDNA were used in the qPCR reactions.
The relative abundance of cDNA fragments was determined
with qPCR using a Maxima SYBR green/ROX qPCR Master Mix
(Thermo Scientiﬁc) and custom-designed primers (0.3 μM ﬁnal
concentration) [Integrated DNA Technologies (IDT), Coralville,
IA, USA] (Table 1) in 20 μL reactions. A two-step cycling protocol
was performed: initial denaturation 95°C, 10min; denaturation
95°C,15 s; annealing/extension 60°C, 60 s. Each run consisted
of 40 cycles, and each sample was run in triplicate. Gene expres-
sion levels were determined with qRT-PCR and the Maxima
SYBR green/ROX qPCR Master Mix (Thermo Scientiﬁc) with
custom-designed primers (0.3 μM ﬁnal concentration, IDT for
primer sequences see Table 1) in 20 μL reactions. Initial
denaturation was at 95°C, 10 min; denaturation 95°C, 15 s;
annealing/extension 60°C, 60 s. Each run consisted of 40 cycles,
and each sample was run in triplicate. Primer speciﬁcity was
veriﬁedwith dissociation curve analyses. Gene expression levels
were normalized to the geometric average of the expression of
two housekeeping genes (RPS5 and 28S ribosomal RNA)
according to (Vandesompele et al., 2002).
Relative expression of transgene and
endogenous mRNAs
The high expression of the human transgene led to up-
regulation of the endogenous rabbit KCNQ1 and KCNE1
mRNAs (Figure 3). The expression level of the rabbit β-myosin
heavy chain mRNA (MYH7), whose promoter was directingAnnealing
temperature Reference
-3′
60°C (Atkinson et al., 2011)
-3′5′-
′
60°C (Atkinson et al., 2011)
-3′5′- 60°C (Atkinson et al., 2011)
;
-3′
60°C This publication
C-3′
60°C (Atkinson et al., 2011)
Figure 3
Quantitative determination of KCNE1 speciﬁc and related mRNAs in
ventricular tissue of transgenic rabbits. G52R-JTJKK and littermate
controls. Relative quantities of mRNAs in the left ventricular apex of
transgenic rabbit hearts. The data shown derive from the pooled
cDNA of two females and two bucks from both the transgenic and
the littermate control groups. The rabbits were sexually mature
adults, weighed 3–3.5 kg and were 5 months old. Gene expression
levels were normalized to the geometric average of the expression
of two housekeeping genes (RPS5 and 28S ribosomal RNA).
LQT5 transgenic rabbits BJPthe G52R-KCNE1 transgene expression, also slightly
increased the endogenous mRNA levels in the transgenic
rabbits compared with wild type (Figure 3).
Western blotting
Left ventricular tissue samples were snap-frozen in liquid N2
and stored at 80°C. To obtain sufﬁcient tissue for protein
extraction, samples from six to seven hearts were pooled in
three groups: a wild-type (n = 7 hearts) and two transgenic
groups (transgenic 1 and 2, n = 6 hearts each). Tissue samples
were homogenized in liquid N2, and 200 mg was homoge-
nized in ice-cold lysis-buffer (20 mM Tris-HCl pH 7.4, 250
mM sucrose, 0.1% protease inhibitor cocktail (Sigma, St.
Louis, MO, USA). After homogenization and centrifugation
(2000 g, 15 min), the supernatant was centrifuged at 100
000 g (45 min), and the pellet re-suspended in lysis buffer.
Protein content was determined with the Lowry method.
Membrane protein samples were separated on a 12% poly-
acrylamide denaturing Tris-glycine gel and transferred to
PVDFmembranes (MerckMillipore, Billerica, MA, USA). After
blocking in 5% non-fat milk, membranes were labelled over-
night at 4°C with the anti-KCNE1 antibody (raised against
amino acids 67–130 of human KCNE1 (Abcam) (1:2000).
The bound anti-KCNE1 antibody was detected with
HRP-conjugated goat anti-mouse secondary antibody
(1:8000) at room temperature for 1 h. Blots were developed
with ECL-plus (GE Healthcare, Little Chalfont, UK) and
developed on X-ray ﬁlms (Amersham Biosciences, GE
Healthcare, Little Chalfont, UK). For loading veriﬁcation,
Ponceau staining was performed. Band-intensities were
measured using IMAGEJ software (NIH), and signals were
normalized to corresponding Ponceau stains.NanoPro analysis
Cell and tissue samples were lysed with RIPA lysis buffer, DMSO
Inhibitor Mix and Aqueous Inhibitor Mix (Protein Simple,
Wallingford, CT, USA). Protein concentration was determined
by NanoDrop (NanoDrop Technologies, Thermo Fischer
Scientiﬁc, Waltham, MA, USA) and diluted to 0.1 mg·mL1.
Lysates were mixed with ampholyte premix (3–10 pI) and
ﬂuorescently labelled isoelectric-point standards for analysis (pI
Standard Ladder 1) on the NanoPro100 system (Cell Biosciences,
Protein Simple,Wallingford, CT,USA). TheNanopro protein data
were obtained from40weeks old,male rabbit heart tissue samples
from the same litter. The pI for rabbit KCNE1 was determined
with wild-type rabbit heart-tissue samples. Capillary isoelectric
focusing electrophoresis was carried out at 15 000 microwatts
for 30 min. The separated proteins were immobilized to the
capillary wall by exposing to UV light for 100 s. Immunoprobing
was with the same anti-human KCNE1 primary antibody
(50-times dilution) as for Western blotting and then probed with
the HRP-conjugated goat anti-mouse secondary antibody
(ProteinSimple). Luminol and peroxidase mixture (ProteinSimple)
was added to generate chemiluminescent light, captured by a
charge-coupled device camera. The digital image was analysed
with COMPASS software (v1.8.0; Cell Biosciences).
Immunohistochemistry and confocal
microscopy
Rabbit ventricular cardiomyocytes were enzymically isolated as
described previously (Varro et al., 1996) and ﬁxed with acetone.
Samples were rehydrated and blocked for 1 h in PBST (PBS with
0.01% Tween) with 5% BSA (Sigma) at room temperature.
Cells were incubated for 1.5 h at room temperature with pri-
mary antibody (mouse monoclonal anti-human KCNE1, Abcam)
at 1:2000 followed by three 1 min washes with PBS and 1 h
incubation with secondary antibody (ﬂuorescein isothiocyanate
(FITC)-labelled anti-mouse IgG) (Sigma-Aldrich) at 1:300. Cover
slips containing the samples were mounted in Aqua Poly/Mount
(Polysciences Inc., Warrington, PA, USA). Fluorescent images
were captured by Olympus FV1000 (Tokyo, Japan) confocal
laser-scanning microscope with identical parameter settings.
Voltage clamp measurements
Single ventricular myocytes were obtained by enzymic dissocia-
tion of isolated wild-type and transgenic rabbit hearts. Following
heparin administration (400 NE·kg1, i.v.), sedation with
xylazine (1 mg·kg1, i.v.) and thiopental (30 mg·kg1, i.v.)-in-
duced anaesthesia, each heart was rapidly removed through a
right lateral thoracotomy and placed into cold (4–8°C) solution
with the following composition (in mM): NaCl 135, KCl 4.7,
KH2PO4 1.2, MgSO4 1.2, HEPES 10, NaHCO3 4.4, glucose 10,
taurine 20, CaCl2 1, (pH 7.2). The heart was then mounted on
a modiﬁed, 60 cm high Langendorff column and perfused with
oxygenated perfusate of the same composition warmed to
37°C. After 3–5 min of perfusion to ﬂush blood from the cor-
onary vasculature, the perfusate was switched to one having
no exogenously added calcium (i.e. to one that was nominally
Ca2+-free) until the heart ceased to contract (~8–10 min).
Enzymic digestion was accomplished by perfusion with the
same, nominally Ca2+-free solution with 290 U·mL1
collagenase (Worthington Type 2) and 30 μM CaCl2. After
10-15 min perfusion, the heart was removed from the aorticBritish Journal of Pharmacology (2016) 173 2046–2061 2051
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1 mM CaCl2 warmed to 37°C for 10 min. Then, the tissue
was minced into small chunks, and following gentle agitation,
myocytes were separated by ﬁltering the resulting slurry
through a nylon mesh. Myocytes were ﬁnally harvested by
gravity sedimentation. Once the majority of individual
myocytes settled to the bottom of the container, the superna-
tant was decanted and replaced with Tyrode’s solution, and
the myocytes were resuspended by gentle agitation. This
procedure was repeated twice more, and the resulting myocyte
suspension was stored in HEPES-buffered Tyrode’s solution at
room temperature.
One drop of cell suspension was placed within a transpar-
ent recording chamber mounted on the stage of an inverted
microscope (Olympus IX51, Olympus), and individual
myocytes were allowed to settle and adhere to the bottom of
the chamber for at least 5 min before superfusion was
initiated. HEPES-buffered Tyrode’s solution was used as the
normal superfusate. This solution contained (in mM): NaCl
144, NaH2PO4 0.4, KCl 4.0, CaCl2 1.8, MgSO4 0.53, glucose
5.5, andHEPES 5.0 at pH of 7.4. Patch clampmicropipettes were
fabricated from borosilicate glass capillaries using a P-97
Flaming/Brown micropipette puller (Sutter Co., Novato, CA,
USA). These electrodes had resistances between 1.5 and 2.5
MΩ after ﬁlling with pipette solution containing (in mM):
KOH 110, KCl 40, K2ATP 5, MgCl2 5, EGTA 5, GTP 0.1 and
HEPES 10, when measuring K+ current. The pH of the pipette
solution was adjusted to 7.2 by aspartic acid.
Membrane currents were recorded with Axopatch 200B
patch-clamp ampliﬁers (Molecular Devices, Sunnyvale, CA,
USA) using the whole cell conﬁguration of the patch clamp
technique. Membrane currents were digitized and recorded un-
der software control (DIGIDATA 1440A, pClamp 10, Molecular
Devices, Sunnyvale, CA, USA) after low-pass ﬁltering at 1 kHz.
The inward rectiﬁer (IK1), transient outward (Ito), rapid
(IKr) and slow (IKs) delayed-rectiﬁer potassium currents were
recorded in rabbit ventricular myocytes. Nisoldipine, gift
from Bayer AG, Leverkusen, Germany (1μM) was added to
the bath solution to block the L-type Ca2+ current (ICa,L).
When IKr was recorded, IKs was inhibited by using the
selective IKs blocker HMR 1556 (0.5 μM). During IKs measure-
ments, IKr was blocked by 0.5 μMdofetilide (Sequoia Research
Products Ltd., Pangbourne, UK), and the bath solution
contained 0.1 μM forskolin (Sigma, St. Louis, MO, USA). All
experiments were performed at 37°C.
ECG recording and evaluation
Since different types of anaesthetics can inﬂuence cardiac
ion channels, rabbits were anaesthetized either with
ketamine-S/xylazine i.m. (12.5 and 3.5 mg·kg1) or thiopen-
tal (50 mg·kg1) in the marginal ear-vein. A catheter was
inserted into the carotid artery for blood-pressure measure-
ment. The right jugular vein was cannulated for i.v. drug
administration.
Blood pressures and electrocardiograms were continuously
recorded, digitized and stored for off-line analysis. RR andQT in-
tervals weremeasured as the average of 30 beats. For QT-interval
measurements, published guidelineswere followed (Farkas et al.,
2004). The frequency-corrected QT interval (QTc) was calcu-
lated by a speciﬁc formula for thiopental-anaesthetized rabbits
(Batey and Coker, 2002): QTc = QT–[0.704 * (RR-250)]. In2052 British Journal of Pharmacology (2016) 173 2046–2061ketamine/xylazine anaesthetized animals, heart rate-corrected
QT-indices were calculated as: QTi (%) = QTmeasured *
100/QTexpected; QTexpected = 86 + 0.22 * RR) as described
previously (Brunner et al., 2008).
I.v. infusions were administered with a programmable infu-
sion pump (Terufusion TE-3, Terumo Europe, Leuven, Belgium).
Bothwild-type and transgenic rabbits receiveddofetilide (Gedeon
Richter Ltd., Budapest, Hungary) 20 μg·kg1 over 10 min.
Short-term variability of RR and QT intervals
The short-term beat-to-beat variability of the QT interval was
calculated as a marker that reliably predicts arrhythmia-
propensity in animal-models (Thomsen et al., 2004; Lengyel
et al., 2007) and patients (Hinterseer et al., 2009, 2010).
Poincaré plots were constructed by plotting all RR and QT
values against their preceding values (Figure 9A) to character-
ize the temporal instability of beat-to-beat heart rate and
repolarization. In case of TdP arrhythmia, the measurements
were taken prior to TdP. Beat-to-beat short-term variability
(STV) of RR or QT intervals was calculated as: STV = ∑ |Dn+1
 Dn| (30x√2)1, with D the duration of QT or RR interval.
STV represents the mean orthogonal distance to the line of
identity on the Poincaré plot; the estimation of beat-to-beat
instability of RR and QT intervals is as described previously
(Brennan et al., 2001).
Data and statistical analysis
All studies in this manuscript followed the editorial on
experimental design and analysis in pharmacology (Curtis
et al., 2015). Data are shown as means ± SEM. Graphical
and statistical data analysis was carried out using ORIGIN
8.1 (Microcal Software, Northampton, MA, USA). Results
were compared using Student’s t-tests for paired and
unpaired data as appropriate. The incidence of arrhythmias
was compared using χ2-test with Yates’ correction.
Differences were considered signiﬁcant when P < 0.05.Results
G52R-KCNE1 localization
Histological examination indicated an absence of structural
abnormalities in transgenic hearts. Ventricular cardiomyocytes
from a transgenic rabbit showed intense KCNE1/minK ﬂuores-
cence (Figure 4D). The membrane localization of G52R-KCNE1
is consistent with observations that G52R-KCNE1 assembles
and trafﬁcs correctly (Harmer et al., 2010).
Cellular electrophysiology
Myocytes isolated from transgenic rabbits expressed moderately
but signiﬁcantly larger transient outward current (Ito) than wild-
type rabbits (Figure 5A). There was no difference in inward-
rectiﬁer potassium current (IK1) density between wild-type and
transgenic myocytes (Figure 5B). There was no difference in the
amplitude (Figure 6A) of the IKr tail current at 40 mV between
wild-type and transgenic myocytes. Similarly, the activation time
constant of IKr was not different between the wild-type and
transgenic myocytes. The fast deactivation time constant of IKr
(at 40 mV, test potential: 30 mV) was slightly faster in
transgenic rabbit cells compared with wild-type (Figure 6B).
Figure 4
Detection and quantitation of the mutant human minK in transgenic rabbit heart. (A) Representative proﬁle of NanoPro analysis and quantitation
of the G52Rmutant and wild-type rabbit minK proteins in the F1 hemizygote rabbit heart ventricles (#G52R-JTJKK). (B) Changes in the membrane
protein content of KCNE1. RepresentativeWestern blots (upper panel) and quantitative evaluation (lower panel) of the membrane protein extracts
isolated from the pooled non-transgenic and two pools of G52R transgenic ventricles. (C) Due to the highly homologous regions of the human
and rabbit KCNE1 amino acid sequences, the anti-KCNE1 antibody detected an approximately 28 kDa protein both in the non-transgenic
littermate control and G52R transgenic rabbit heart samples. (D) Representative immunoﬂuorescent images of rabbit ventricular cardiomyocytes,
labelled with anti-human KCNE1 antibody. Left panel shows an image of a cardiomyocyte isolated from the non-transgenic rabbit and right panel
from a #G52R-JTJKK transgenic animal labelled with both the primary and secondary antibodies. Bar represents 25 μm.
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Figure 5
The density of Ito (A) and IK1 (B) in rabbit ventricular myocytes. Representative Ito current traces recorded from wild-type (WT) and transgenic (TG)
ventricular myocytes are shown in panel A (left). Current–voltage relations (right) demonstrate higher Ito density in TG rabbits compared with WT rabbits.
Panel (B) illustrates steady-state current–voltage curves (left) demonstrating no differences in density of IK1 between WT and TG rabbits. The outward cur-
rent sections of the curves are enlarged on the right. Insets show the applied voltage protocols. Values are means ± SEM. *P < 0.05 versus WT littermates.
BJP P Major et al.No difference was observed in IKs tail-current amplitude
between transgenic and wild-type rabbits (Figure 7). There
were no differences between the stimulating effect of
forskolin in wild-type versus transgenic rabbits (Figure 7A).
The activation kinetics of IKs were not different, but the deac-
tivation kinetics (at40mV, test potential: 50mV) wasmark-
edly and signiﬁcantly faster, in transgenic-rabbit myocytes
compared with wild-type rabbits (Figure 7B). These changes
would be expected to reduce phase-3 repolarizing current,
particularly in the presence of a repolarization stress. The subtle
repolarization abnormalities associated with our model were
reﬂected in cellular action-potential recordings (Supplemental
Figure 1), which showed a signiﬁcant increase in APD-variability
but not in APD-increase resulting from dofetilide exposure
in transgenic versus wild-type rabbits.ECG parameters and arrhythmias
During anaesthesia with ketamine/xylazine, which does not
affect cardiac repolarization (Odening et al., 2008), there
was a slightly but signiﬁcantly longer QTi in LQT5-transgenic2054 British Journal of Pharmacology (2016) 173 2046–2061versus wild-type littermates (104 ± 0.9% vs. 98.9 ± 1.0%,
P< 0.001, Figure 8). No sex-related differences were observed.
Examples of ECG recordings are shown in Supplemental
Figure 2. In arrhythmia provocation experiments under thio-
pental anaesthesia, which blocks IKs (Sakai et al., 1997), there
were no signiﬁcant differences in any ECG intervals between
wild-type and transgenic animals at baseline (Table 2). The
short-term variability of the RR interval (STVRR) was also
similar in both groups, both at baseline and following
dofetilide (Figure 9C). Figure 9A and B shows Poincaré plots
of QT-intervals of representative individual wild-type and
transgenic rabbits. As representative plots (Figure 9A and B)
and grouped data show (Figure 9D), the short-term QT-
interval variability (STVQT) was already greater in transgenic
rabbits at baseline. Administration of dofetilide (20 μg·kg1,
i.v.) prolonged the QT and QTc intervals signiﬁcantly in both
groups (Table 2). However, dofetilide signiﬁcantly decreased
heart rate only in transgenic animals (Table 2). Dofetilide
caused a further and signiﬁcant increase in STVQT in trans-
genic animals (Figure 9D). While dofetilide led to similar
QTc prolongation in both groups, its STVQT-increasing effect
Figure 6
The density of IKr (A) in rabbit ventricular myocytes. Representative IKr tail current traces recorded from wild-type (WT) and transgenic (TG)
ventricular myocytes are shown on the left. Current–voltage relations (right) demonstrate no differences in density of IKr between WT and TG
rabbits. Inset shows the applied voltage protocol. Bar diagrams in panel (B) illustrate the activation and deactivation (fast and slow) time constants
in WT and TG ventricular myocytes. Values are means ± SEM. *P < 0.05 versus WT littermates.
LQT5 transgenic rabbits BJPwas more pronounced and accompanied by more arrhyth-
mias in transgenic animals. Dofetilide provoked TdP arrhyth-
mias in 3/11 (27%) wild-type animals versus 12/15 (80%) of
transgenic rabbits (P < 0.001, Figure 9E). In transgenic ani-
mals, the durations of TdP episodes were also signiﬁcantly
longer than those observed in wild-type rabbits (Figure 9F).Discussion
This is the ﬁrst study to report the creation and primary
characterization of a transgenic LQT5 pro-arrhythmia model inrabbits. The reliable prediction of pro-arrhythmic risk
associated with pharmacological therapy is essential to reduce
the incidence of serious drug-induced arrhythmias in the clinical
setting. Cardiac electrophysiological safety assessment remains
unsatisfactory (Farkas and Nattel, 2010). Current in vitro and
in vivo proarrhythmiamodelsmostly rely on investigating effects
in healthy tissues, animals and volunteers (ICHE14, 2005; ICH-
S7B, 2005). New models with better predictive value for
proarrhythmic risk are needed, to better reﬂect clinical situations
at risk of drug-induced arrhythmias, particularly in patients with
remodelled myocardium (Nattel et al. 2007) exhibiting impair-
ment of repolarization reserve (Varro and Baczko, 2011).British Journal of Pharmacology (2016) 173 2046–2061 2055
Figure 7
The density of IKs (A) in absence and presence of 5 μM forskolin in rabbit ventricular myocytes. Representative IKs current traces recorded from
wild-type (WT) and transgenic (TG) ventricular myocytes are shown in panel A (left). Current–voltage relations (right) demonstrate no differences
in density of IKs between WT and TG rabbits. Inset shows the applied voltage protocol. Bar diagrams in panel (B) illustrate the activation and
deactivation time constants in WT and TG ventricular myocytes. Values are means ± SEM. *P < 0.05 versus WT littermates.
BJP P Major et al.Already existing in vivo proarrhythmia models with
impaired repolarization reserve include a dog model with
chronic atrioventricular block (Vos et al., 1998). In this model,
ventricular hypertrophy and bradycardia develop, and the con-
sequent down-regulation of IKs leads to reduced repolarization
reserve and increased arrhythmia susceptibility (Vos et al.,
1998; Volders et al., 1999). Another approach is the acute
pharmacological inhibition of IKs by HMR-1556 (Lengyel
et al., 2007) mimicking reduced repolarization reserve.
Loss-of-function mutations in repolarizing and gain-of-function
mutations in depolarizing currents cause congenital long QT
syndromes with impaired repolarization and increased sudden2056 British Journal of Pharmacology (2016) 173 2046–2061death risk (Moss andKass, 2005). The twomost common forms
of congenital LQT (LQT1 and LQT2) were modelled by expres-
sion of humanmutant KCNQ1 and KCNH2 genes in transgenic
rabbits in a landmark study by Brunneret al. (2008). Both LQT1
and LQT2 rabbits exhibited markedly prolonged QT intervals,
and LQT2 transgenic rabbits showed a high incidence of
sudden death (Brunneret al., 2008; Odening et al., 2010). These
two transgenic rabbit models mimic the human LQT1 and
LQT2 phenotypes and are extremely useful tools for studying
mechanisms of sudden death, as shown by at least 13 addi-
tional publications since the original paper (see (Duranthon
et al., 2012). On the other hand, the importance of ‘silent’ or
Figure 8
Heart rate corrected QT index in anaesthetized rabbits. Plots
indicating the heart-rate corrected QT-indices (QTi) in LQT5
transgenic (n = 21) and wild-type littermate (WT; n = 22) rabbits
under anaesthesia with ketamine/xylazine. Mean ± SEM are indicated
as horizontal lines. P < 0.001.
LQT5 transgenic rabbits BJP‘subclinical’ LQT cases should be emphasized, where impair-
ment of repolarization reserve does not necessarily result in
clinically obvious QT-prolongation, but the heart is more
susceptible to arrhythmia development (Roden, 2006; Varro
and Baczko, 2011).
The present study aimed at the creation and primary char-
acterization of a novel transgenic rabbit model with latent
impairment of repolarization reserve and a weaker phenotype
compared with the LQT1 and LQT2 models.
Pronuclear microinjection results in concatemers with
multicopy transgene integrations. Our data shows that the
transgenic line examined in detail carries the transgene inte-
grated at two different loci on Chr 11 at high copy numbers.
The quantity in this line of the mutant human minK protein
was twice that of the endogenous minK (Figure 4A, B, C). The
data conﬁrmed our earlier observations, where a minigene type
transgene construct integrated at high copy numbers and
resulted in a relatively high recombinant protein expression in
transgenic rabbit milk (Bodrogi et al., 2006), despite the known
phenomenon that the presence of multiple transgene homolo-
gous copies within a concatemer array can have a repressive
effect upon gene-expression (Garrick et al., 1998).Table 2
Different ECG parameters in WT and TG rabbits at baseline and following th
WT baseline WT prior to arrhythmia WT DO
PQ (ms) 69.6 ± 2.83 70.8 ± 2.49 71.9 ± 3.
QRS (ms) 36.2 ± 1.28 39.2 ± 2.13 40.6 ± 3.
RR (ms) 226.6 ± 7.93 222.5 ± 9.61 228.2 ± 8.
HR (1 min-1) 267.9 ± 9.11 268.9 ± 8.88 267.3 ± 10
QT (ms) 139.3 ± 4.54 145.5 ± 4.77 159.9 ± 5.
QTc (ms) 155.8 ± 4.09 162.1 ± 2.81 175.4 ± 3.
Dof, measured at 10 min after the end of dofetilide infusion; HR: heart rate; T
#P < 0.05 versus baseline in the same groupIn the present study, functional effects of the G52R-KCNE1
mutation were investigated in left ventricular myocytes
obtained from wild-type and transgenic rabbit hearts. There
were no differences in the amplitude of the IK1 current and tail
currents of IKr and IKs. Current amplitudes and densities can be
inﬂuenced by the cell isolation procedure, whichmay attenuate
differences between study groups, in spite of relatively large
numbers of rabbits (8–24) and cells (20–64). On the other hand,
IKr/IKs deactivation kinetics were signiﬁcantly affected by the
transgene, potentially accounting for the in vivo phenotype.
The functional importance of the moderate augmentation of
Ito in transgenic rabbits is difﬁcult to interpret in the rabbit heart,
in which the Ito is carried mainly, but not exclusively, by Kv1.4
channels (Zicha et al., 2003), which have slow (>1 s time-
constant) recovery kinetics from inactivation. The exact role of
Ito in ventricular repolarization at normal rabbit heart rates - in
the range of 200–250 beats min-1 at rest - is uncertain because
rabbit Ito may be largely inactivated at physiological heart rates.
The most important cellular ﬁnding in this study is the
accelerated deactivation kinetics of IKs and IKr in the trans-
genic rabbits, compared with their wild-type littermates.
Accelerated deactivation causes more rapid channel closure
and consequently lower densities of IKs and IKr during the
action potential. These functional changes impair repolariza-
tion reserve and might explain the increased susceptibility of
transgenic rabbits to arrhythmias, in our in vivo studies. The
accelerated deactivation of IKs in native ventricular
cardiomyocytes expressing the mutant G52R-KCNE1 in our
study contrasts with the ﬁndings obtained in Xenopus
oocytes co-expressing wild-type KCNE1 and G52R-KCNE1
with KCNQ1, where the IKs current amplitude was decreased
by 50% (Ma et al., 2003). In CHO cells, co-expression of
KCNQ1 with G52R-KCNE1 produced a current devoid of
the characteristic slow activation of IKs, and the current
density was similar to those in cells expressing only the
KCNQ1 without any type of KCNE1 (Harmer et al., 2010).
The reasons for these conﬂicting results in native rabbit
cardiomyocytes and various cellular expression systems are
not known. However, accumulating evidence suggests that
KCNE1 is not the only regulatory subunit that associates with
KCNQ1, and KCNE2, KCNE3, possibly KCNE4 and KCNE5 also
form channel complexes with KCNQ1, and these complexes
play potential physiological roles (Bendahhou et al., 2005;
Lundquist et al., 2005). In addition, although KCNE1 is
established primarily as a KCNQ1 subunit, there is evidence thate administration of the IKr blocker dofetilide
F TG baseline TG prior to arrhythmia TG DOF
04 67.9 ± 1.67 69.1 ± 1.48 71.6 ± 3.86
26 34.6 ± 1.10 35.4 ± 1.71 40.1 ± 2.79
96 230.1 ± 5.44 235.8 ± 6.45 255.1 ± 9.78#
.1 262.9 ± 5.47 255.8 ± 6.12 244 ± 9.04#
97# 140.2 ± 2.49 146.7 ± 5.22 172.9 ± 5.24#
70# 154.5 ± 2.86 156.3 ± 2.07 175.5 ± 3.63#
G, transgenic; WT, wild type.
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Figure 9
Short-term variability of the RR and QT intervals and Torsade-de-Pointes in thiopental anaesthetized rabbits. (A–B) Representative Poincaré plots
demonstrate higher short-term beat-to-beat variability of the QT interval (STVQT) in anaesthetized transgenic (TG) rabbits at baseline conditions
compared with wild-type (WT) animals. Following the administration of the IKr blocker dofetilide, STVQT further and markedly increased only in
transgenic animals. (C) There were no differences in short-term variability of the RR interval (STVRR) between WT and TG rabbits either at baseline
conditions or following the administration of the IKr blocker dofetilide. (D) Short-term variability of the QT interval (STVQT) was higher in TG
animals at baseline conditions and following dofetilide infusion, indicating increased temporal instability of repolarization in TG rabbits. (E)
Accordingly, TG animals exhibited Torsade-de-Pointes (TdP) with signiﬁcantly higher incidence. (F) The duration of TdP episodes was signiﬁcantly
longer in TG rabbits, expressed as the log10 of duration in seconds (to allow statistical comparison of data with normal distribution). Dof: dofetilide
(20 μg·kg1, i.v.); n = 11 and 15 animals in WT and TG groups, respectively on panels (C) to (E); n = 3 and 12 animals on panel (F); *P< 0.05 versus
wild type; #P < 0.05 versus baseline in the same group.
BJP P Major et al.it may also play a role in IKr (Yang et al., 1995; McDonald et al.,
1997; Ohno et al., 2007). The varying contributions of different
accessory subunitsmay account for the different effects ofmuta-
tions in different expression systems.
During in vivo characterization, no spontaneous sudden
deaths were observed in LQT5-transgenic rabbits. ECG stud-
ies in xylazine/ketamine-anaesthetized rabbits revealed a
slight but signiﬁcant prolongation of the heart rate-corrected
QT index in LQT5-rabbits, indicating mild prolongation of
repolarization (Figure 8). Contrasting with observations
during anaesthesia with ketamine/xylazine, which does not
affect repolarizing ion-currents (Odening et al., 2008), during
thiopental-anaesthesia, there were no differences in the QT2058 British Journal of Pharmacology (2016) 173 2046–2061or frequency-corrected QTc intervals between LQT5 rabbits
and their wild-type littermates (Table 2). Because thiopental
has IKs-blocking effects (Sakai et al., 1997.), unlike
xylazine/ketamine (Baum, 1993), it is likely that the small
baseline repolarization differences disappeared following
thiopental anaesthesia. Even under thiopental anaesthesia;
however, the short-term variability of the QT interval that is
an ECG biomarker for proarrhythmic risk (Atiga et al., 1998;
Varkevisser et al., 2012) was signiﬁcantly greater in LQT5
rabbits (Figure 9 A-B, D), suggesting increased repolarization
instability already at baseline. To compare the arrhythmia-
susceptibility of LQT5 rabbits with reduced repolarization
reserve to wild-type littermates, the IKr blocker dofetilide was
LQT5 transgenic rabbits BJPadded. As expected, dofetilide prolonged the QT interval in
both groups (Table 2). Dofetilide further increased STVQT in
LQT5-rabbits and provoked typical drug-induced polymorphic
ventricular tachycardia, Torsade de Pointes, in a much larger
number of LQT5-animals compared with wild type (Figure 9E),
and these episodes lasted signiﬁcantly longer (Figure 9F). These
observations agree with other proarrhythmia studies in models
with reduced repolarization reserve, such as dogs with chronic
AV-block (Thomsen et al., 2004) and anaesthetized rabbits sub-
jected to pharmacological block of IKs (Lengyel et al., 2007).
Although we did not observe any evidence of cardiac structural
or functional disturbances in transgenic rabbits, formal studies
with echocardiographic assessment of cardiac and structure
should be performed in the future to exclude any subtle
alterations occurring in the model.
Further studies are needed to detail the cellular electro-
physiological mechanisms responsible for the increased
arrhythmia susceptibility observed in LQT5-rabbits, espe-
cially in the light of data indicating that (i) chronic loss of
function of one repolarizing current can lead to compensa-
tory up-regulation of other K+-channels (Xiao et al., 2008)
and (ii) different KCNE-encoded proteins do not exclusively
associate with KvLQT1 to form IKs channels, but may be
involved in the assembly of other ion channels (Abbott and
Goldstein 2002; Um and McDonald, 2007). Future studies
should also evaluate all important ionic currents in a large num-
ber of native ventricular cardiomyocytes isolated from LQT5
transgenic and wild-type littermate animals at different voltage
levels focusing on channel kinetics, but such work is beyond
the scope of the present study due to the limited availability of
such animals. In addition, it would be interesting to create a
study involving wild-type KCNE1 overexpression, to compare
the resulting phenotype with that of mutant KCNE1 overex-
pressing rabbits. Furthermore, studies of the effects of additional
repolarization-stresses, such as adrenergic stimulation, would be
appropriate. Finally, it would be useful to examine whether
changes occur in other ion-currents like INa and ICa,L, because
they might be altered as part of the cellular adaptation to
changes in electrical function induced by the mutation.
In conclusion, we report the successful creation of a novel
transgenic LQT5 rabbit model based on the cardiac-speciﬁc
overexpression of human KCNE1 carrying a G52R missense.
These rabbits exhibit reduced repolarization reserve but no strik-
ing repolarization disturbances or serious ventricular arrhyth-
mias at baseline. However, LQT5 rabbits are more susceptible
to arrhythmias than wild-type littermates upon repolarization
stress, indicating that they may be suitable to model the
challenging clinical situation of ‘silent’ LQT. This model can
also provide further insights into the mechanisms underlying
arrhythmias and sudden cardiac death based on repolarization
disturbances and may represent a novel model for testing the
pro-arrhythmic potential of new drugs under development.Acknowledgements
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Figure S1 Effect of 100 nM dofetilide on the action potential
duration and on the short-term variability of the action potential
duration in rabbit ventricular myocytes. The upper panels show
representative action potential recordings in the absence and
presence of 100nMdofetilide fromwild type (left) and transgenic
(right) ventricular myocytes. Bar graphs in the lower panels illus-
trate APD90 (left) and the short-term variability of APD90 (right) in
control conditions and in the presence of 100 nM dofetilide in
wild type (WT) and transgenic (TG) ventricularmyocytes. Values
are means ± standard errors of the means. The measurements
were taken from 6 WT and 6 TG rabbit hearts, “n” values on
the graph represent the number of cells in each group.
Figure S2 Representative ECG recordings from thiopental
anaesthetized wild type littermate (upper panel) and transgenic
(lower panel) rabbits at baseline (control) and following the i.v.
administration of dofetilide (20 μg kg-1).British Journal of Pharmacology (2016) 173 2046–2061 2061
